Chung Yoo Seung, Kim Jee Young, Bae Ja-Seong, Song Byung-Joo, Kim Jeong Soo, Jeon Hae Myung, Jeong Sang-Seol, Kim Eung Kook, Park Woo-Chan
Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Thyroid. 2009 Mar;19(3):241-6. doi: 10.1089/thy.2008.0244.
Cervical lymph node metastases are quite common in papillary thyroid cancer (PTC) and they usually spread in a contiguous fashion. However, "skip metastasis," defined as lateral lymph node metastasis without central lymph node metastasis, also occurs in patients with PTC. There is little information regarding skip metastasis in papillary thyroid microcarcinoma (PTMC). The goal of this study was to determine the prevalence and associated clinical and imaging features of skip metastasis in PTMC.
We performed a retrospective study of 245 patients with PTMC who underwent either thyroidectomy and central lymph node dissection or thyroidectomy, central lymph node dissection, and lateral lymph node dissection if preoperative ultrasonography or computed tomography suggested lateral node metastasis. Clinicopathologic results were reviewed, and the patterns of cervical lymph node metastasis were analyzed.
Cervical lymph node metastases were present in 26.5% of cases. The frequency of lymph node metastases was 21.8% in the group that only had thyroidectomy and central lymph node dissection and 51.3% in the group that had thyroidectomy, central lymph node dissection, and lateral lymph node dissection. Younger age, larger tumor size, multiplicity, bilaterality, encapsulation, extrathyroid extension, and lymphatic invasion were associated with metastasis to nodes in the central or lateral compartment. Lateral lymph node dissection was performed in 15.9% of patients. Skip metastasis was observed in 7.7% of the cases in which combined central and lateral node dissection was performed. No features of the primary thyroid tumor could be associated with the development of skip metastasis.
Skip metastases occur in a minority of patients with PTMC. We recommend, therefore, that preoperative studies in patients suspected of having PTMC focus not only on nodes in the central compartment but also lateral cervical nodes since the information obtained would guide the extent of surgery.
颈部淋巴结转移在乳头状甲状腺癌(PTC)中相当常见,且通常以连续方式扩散。然而,“跳跃转移”,即定义为无中央淋巴结转移的侧方淋巴结转移,也见于PTC患者。关于甲状腺微小乳头状癌(PTMC)跳跃转移的信息较少。本研究的目的是确定PTMC中跳跃转移的发生率以及相关的临床和影像学特征。
我们对245例接受甲状腺切除术及中央淋巴结清扫术的PTMC患者进行了回顾性研究,若术前超声或计算机断层扫描提示侧方淋巴结转移,则行甲状腺切除术、中央淋巴结清扫术及侧方淋巴结清扫术。回顾临床病理结果,分析颈部淋巴结转移模式。
26.5%的病例存在颈部淋巴结转移。仅行甲状腺切除术及中央淋巴结清扫术的组中淋巴结转移频率为21.8%,而行甲状腺切除术、中央淋巴结清扫术及侧方淋巴结清扫术的组中为51.3%。年龄较小、肿瘤较大、多灶性、双侧性、包膜完整、甲状腺外侵犯及淋巴管浸润与中央或侧方区域淋巴结转移相关。15.9%的患者进行了侧方淋巴结清扫术。在进行中央和侧方淋巴结联合清扫术的病例中,7.7%观察到跳跃转移。原发性甲状腺肿瘤的特征与跳跃转移的发生无关。
跳跃转移发生于少数PTMC患者。因此,我们建议,对于疑似PTMC的患者,术前检查不仅应关注中央区域淋巴结,还应关注颈部侧方淋巴结,因为所获得的信息将指导手术范围。